Increased eosinophil activity in acute Plasmodium falciparum infection - Association with cerebral malaria

Clinical and Experimental Immunology

Volumn 112, Issue 2, 1998, Pages 303-307

  Kurtzhals, J A L ^a,b,c   Reimert, C M ^d   Tette, E ^c   Dunyo, S K ^a   Koram, K A ^a   Akanmori, B D ^a   Nkrumah, F K ^a   Hviid, L ^b  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d Mental Health Services CPH   (Denmark)

Author keywords

Eosinophil cationic protein; Eosinophil protein X cerebral malaria; Eosinophils; Malaria; Plasmodium falciparum

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; NEUROTOXIN; SECRETORY PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MALARIA; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EOSINOPHIL; GHANA; HELPER CELL; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHILD; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-5; LONGITUDINAL STUDIES; MALARIA, CEREBRAL; PLASMODIUM FALCIPARUM; RIBONUCLEASES;

EID: 0031802626     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00586.x     Document Type: Article

References (27)

1. Davis TME, Ho M, Supanaranond W, Looareesuwan S, Pukrittayakamee S, White NJ. Changes in the peripheral blood eosinophil count in falciparum malaria. Acta Trop 1991; 48:243-5.
2. Reiley CG, Barrett O Jr. Leukocyte response in acute malaria. Am J Med Sci 1971; 262:153-8.
3. Shanks GD, Wilairatanaporn C. Eosinophilic response to falciparum malaria infections. SE Asian J Trop Med Public Health 1992; 23:795-7.
4. Abdalla SH. Peripheral blood and bone marrow leucocytes in Gambian children with malaria: numerical changes and evaluation of phagocytosis. Ann Trop Paed 1988; 8:250-8.
5. Waters LS, Taverne J, Tai P-C, Spry CJF, Targett GAT, Playfair JHL. Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun 1987; 55:877-81.
6. Durack DT, Ackerman SJ, Loegering DA, Gleich GJ. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci USA 1981; 78:5165-9.
7. Fredens K, Dahl R, Venge P. The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol 1982; 70:361-6.
8. Afari EA, Appawu M, Dunyo S, Baffoe-Wilmot A, Nkrumah FK. Malaria infection, morbidity and transmission in two ecological zones in Southern Ghana. Afr J Health Sci 1995; 2:312-5.
9. Kurtzhals JAL, Rodrigues O, Addae M, Commey JOO, Nkrumah FK, Hviid L. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997; 97:169-74.
10. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991; 138:285-90.
11. Reimert CM, Minuva U, Kharazmi A, Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN): detection by enzyme-linked immunosorbent assay and purification from normal human urine. J Immunol Methods 1991; 141:97-104.
12. Tischendorf FW, Brattig NW, Büttner DW, Pieper A, Lintzel M. Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes. Acta Trop 1996; 62:171-82.
13. Carlson M, Håkansson L, Kämpe M, Stålenheim G, Peterson C, Venge P. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol 1992; 89:131-9.
14. Hällgren R, Bjelle A, Venge P. Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement. Ann Rheum Dis 1997; in press.
15. Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254:279-82.
16. Sanderson CJ. Interleukin-5: an eosinophil growth and activation factor. Dev Biol Stand 1997; 69:23-29.
17. Rubin LA, Kurman CC, Fritz ME et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135:3172-7.
18. Wickramasinghe S, Phillips RE, Looareesuwan S, Warrel DA, Hughes M. The bone marrow in human cerebral malaria: parasite sequestration within sinusoids. Br J Haematol 1987; 66:295-306.
19. Riley EM, Rowe P, Allen SJ, Greenwood BM. Soluble plasma IL-2 receptors and malaria. Clin Exp Immunol 1993; 91:495-9.
20. Afari EA, Dunyo S, Appawu M, Nkrumah FK. In vivo seasonal assessment of Plasmodium falciparum sensitivity to chloroquine in two different malaria endemic communities in Southern Ghana Afr J Health Sci 1994; 1:112-5.
21. Perlmann H, Helmby H, Hagstedt M et al. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol 1994; 97:284-92.
22. Perlmann P, Perlmann H, Flyg BW et al. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect Immun 1997; 65:116-21.
23. Zwingenberger K, Hohmann A, Cardoso de Brito M, Ritter M. Impaired balance of interleukin-4 and interferon-gamma production in infections with Schistosoma mansoni and intestinal nematodes. Scand J Immunol 1991; 34:243-51.
24. Murray J. The biological suppression of malaria: an ecological and nutritional interrelationship of a host and two parasites. Am J Clin Nutr 1978; 31:1363-6.
25. Christensen N, Furu P, Kurtzhals JAL, Odaibo A. Heterologous synergistic interactions in concurrent experimental infection in the mouse with Schistosoma mansoni, Echinostoma revolution, Plasmodium yoelii, Babesia microti, and Trypanosoma brucei. Parasitol Res 1988; 74:544-51.
26. Reimert CM, Poulsen LK, Bindslev-Jensen C, Kharazmi A, Bendtzen K. Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). J Immunol Methods 1993; 166:183-90.
27. Reimert CM, Skov PS, Poulsen LK. A microtiter assay for activation of eosinophils. Allergy 1998; in press.